IFN&#947;-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo | Zendy

Tania Pilli | Zendy; Silvia Cantara | Zendy; Lutz Schomburg | Zendy; Valeria Cenci | Zendy; Sandro Cardinale | Zendy; E Heid | Zendy; E Kuhn | Zendy; Gabriele Cevenini | Zendy; Fausta Sestini | Zendy; Carla Fioravanti | Zendy; Gabriele D'Hauw | Zendy; Furio Pacini | Zendy

Open Access

IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo

Author(s) -

Tania Pilli,

Silvia Cantara,

Lutz Schomburg,

Valeria Cenci,

Sandro Cardinale,

E Heid,

E Kuhn,

Gabriele Cevenini,

Fausta Sestini,

Carla Fioravanti,

Gabriele D'Hauw,

Furio Pacini

Publication year - 2015

Publication title -

european thyroid journal

Language(s) - English

Resource type - Journals

eISSN - 2235-0802

pISSN - 2235-0640

DOI - 10.1159/000439589

Subject(s) - medicine , euthyroid , selenium , thyroiditis , autoimmune thyroiditis , placebo , thyroid , endocrinology , chemokine , immunology , gastroenterology , inflammation , pathology , alternative medicine , materials science , metallurgy

Several studies have suggested that selenium may influence the natural history of autoimmune thyroiditis (AIT). Recently, IFNγ-inducible chemokines (CXCL-9, -10 and -11) were shown to be elevated in AIT patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research